JP2024520577A5 - - Google Patents
Info
- Publication number
- JP2024520577A5 JP2024520577A5 JP2023573662A JP2023573662A JP2024520577A5 JP 2024520577 A5 JP2024520577 A5 JP 2024520577A5 JP 2023573662 A JP2023573662 A JP 2023573662A JP 2023573662 A JP2023573662 A JP 2023573662A JP 2024520577 A5 JP2024520577 A5 JP 2024520577A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- nos
- acid sequences
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163195470P | 2021-06-01 | 2021-06-01 | |
| US63/195,470 | 2021-06-01 | ||
| PCT/EP2022/064703 WO2022253805A1 (en) | 2021-06-01 | 2022-05-31 | Anti-nkg2a antibodies and compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024520577A JP2024520577A (ja) | 2024-05-24 |
| JP2024520577A5 true JP2024520577A5 (cg-RX-API-DMAC7.html) | 2025-06-06 |
Family
ID=82117230
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023573662A Pending JP2024520577A (ja) | 2021-06-01 | 2022-05-31 | 抗nkg2a抗体及び組成物 |
Country Status (17)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4644422A1 (en) * | 2022-12-28 | 2025-11-05 | BioRay Pharmaceutical Co., Ltd. | Anti-nkg2a antibody and use thereof |
| CN121358774A (zh) * | 2023-06-21 | 2026-01-16 | 科望(苏州)生物医药科技有限公司 | 与nkg2a结合的抗体或抗原结合片段及其用途 |
| CN121941711A (zh) * | 2024-02-08 | 2026-04-28 | 翰思艾泰生物医药科技(武汉)股份有限公司 | Nkg2a/cd94靶向抗体及其用途 |
| CN121108342B (zh) * | 2025-09-08 | 2026-03-03 | 北京明璨生物科技有限公司 | 包含抗体和nk细胞的组合物在治疗癌症中的用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002522063A (ja) | 1998-08-17 | 2002-07-23 | アブジェニックス インコーポレイテッド | 増加した血清半減期を有する改変された分子の生成 |
| ATE537190T1 (de) * | 2006-06-02 | 2011-12-15 | Regeneron Pharma | Hochaffine antikörper gegen den humanen il-6- rezeptor |
| MX2010007935A (es) | 2008-01-24 | 2010-08-23 | Novo Nordisk As | Anticuerpo monoclonal humanizado anti-nkg2a humano. |
| AU2015316993B2 (en) * | 2014-09-16 | 2021-03-18 | Innate Pharma | Treatment regimens using anti-NKG2A antibodies |
| EP3209687A1 (en) * | 2014-10-23 | 2017-08-30 | Innate Pharma | Treatment of cancers using anti-nkg2a agents |
| WO2017046774A2 (en) | 2015-09-16 | 2017-03-23 | Prothena Biosciences Limited | Use of anti-mcam antibodies for treatment or prophylaxis of giant cell arteritis, polymyalgia rheumatica or takayasu's arteritis |
| CN116693685A (zh) * | 2016-04-12 | 2023-09-05 | 法国施维雅药厂 | 抗tim-3抗体及组合物 |
| EP3878869A4 (en) | 2018-11-07 | 2023-04-19 | Shanghai Hyamab Biotech Co., Ltd. | NKG2A ANTIBODIES, METHOD OF PRODUCTION THEREOF AND USE THEREOF |
| MX2021005708A (es) * | 2018-11-16 | 2021-09-21 | Bristol Myers Squibb Co | Anticuerpos anti grupo 2a del receptor inhibidor de células asesinas naturales (anti-nkg2a) y usos de los mismos. |
-
2022
- 2022-05-31 CA CA3222040A patent/CA3222040A1/en active Pending
- 2022-05-31 IL IL308695A patent/IL308695A/en unknown
- 2022-05-31 JP JP2023573662A patent/JP2024520577A/ja active Pending
- 2022-05-31 EP EP22732067.8A patent/EP4347651A1/en active Pending
- 2022-05-31 US US17/828,740 patent/US12012450B2/en active Active
- 2022-05-31 TW TW111120182A patent/TW202313683A/zh unknown
- 2022-05-31 MX MX2023014320A patent/MX2023014320A/es unknown
- 2022-05-31 CN CN202280039227.XA patent/CN117460748A/zh active Pending
- 2022-05-31 PE PE2023003150A patent/PE20240372A1/es unknown
- 2022-05-31 WO PCT/EP2022/064703 patent/WO2022253805A1/en not_active Ceased
- 2022-05-31 KR KR1020237043690A patent/KR20240016991A/ko active Pending
- 2022-05-31 AU AU2022286617A patent/AU2022286617A1/en active Pending
- 2022-05-31 BR BR112023024772A patent/BR112023024772A2/pt unknown
- 2022-05-31 PH PH1/2023/553123A patent/PH12023553123A1/en unknown
- 2022-05-31 AR ARP220101426A patent/AR126001A1/es unknown
-
2023
- 2023-11-23 CO CONC2023/0015982A patent/CO2023015982A2/es unknown
- 2023-11-29 CL CL2023003562A patent/CL2023003562A1/es unknown
-
2024
- 2024-05-13 US US18/661,970 patent/US20240294638A1/en active Pending